Migraine Drug Market Size, Share & Trends Analysis

The Migraine Treatment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Migraine Treatment Market:

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

According to The Business Research Company’s Migraine Treatment Global Market Report 2024, The migraine treatment market size has grown strongly in recent years. It will grow from $2.94 billion in 2023 to $3.22 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%.  The  growth in the historic period can be attributed to increased prevalence of migraines, increased healthcare expenditure, improved formulations of existing drugs, expansion of clinical research, development of novel therapies.

The migraine treatment market size is expected to see rapid growth in the next few years. It will grow to $4.78 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%.  The growth in the forecast period can be attributed to growing awareness and education, emergence of monoclonal antibodies, increasing focus on pediatric migraines, expansion of non-pharmacological interventions, global initiatives for migraine research.. Major trends in the forecast period include advancements in therapeutic approaches, wearable devices and digital therapeutics, telemedicine and remote consultations, patient-centric care models, generic drug market growth, oral cgrp inhibitors..

The increasing prevalence of migraine is expected to propel the growth of the migraine treatment market. Migraine refers to a headache that occurs on one side of the brain only and causes severe pain or a pulsing sensation. Migraine treatment can stop future attacks and symptoms. For instance, in June 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, in 2021, 4.3% of persons over the age of 18 reported having a headache or migraine at least once every three months. Therefore, the increasing prevalence of migraine is driving the growth of the migraine treatment market .

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

The migraine treatment market covered in this report is segmented –

1) By Types: Episodic, Migraine With Aura, Chronic, Other Types

2) By Treatment:  Acute/Abortive Treatment, Preventive/prophylactic Treatment, Non-Pharmacological Therapies and Devices

3) By End-User: Hospitals, Clinics, Homecare, Other End-users

Technological innovations are the key trend gaining popularity in the migraine treatment market. Major companies operating in the market are introducing technological innovations to sustain their position in the market. For instance, in March 2021, Neurolief, an Israel-based company that develops proprietary digital therapeutics neuromodulation technology, launched ‘Brain Neuromodulation Technology,’ used for migraine treatment. It is the first non-invasive neuromodulation system used to treat acute migraine at home.

The migraine treatment market report table of contents includes:

 

1. Executive Summary
2. Migraine Treatment  Market Characteristics
3. Migraine Treatment  Market Trends And Strategies
4. Migraine Treatment  Market – Macro Economic Scenario
5. Global Migraine Treatment  Market Size and Growth

.

.

.

31. Global Migraine Treatment  Market Competitive Benchmarking
32. Global Migraine Treatment  Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Migraine Treatment  Market
34. Migraine Treatment  Market Future Outlook and Potential Analysis
35. Appendix

Top Major Players:

. Endo International PLC

. Impax Laboratories Inc

. Johnson & Johnson Inc

. Lannett Company Inc

. Lupin Limited, Merck & Co

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model